by ALG Associate | Mar 11, 2021 | White Paper
The law governing pharmacovigilance lay down rigid details on what pharmaceutical firms must do in the event of analysing a serious adverse event and indeed what constitutes a serios adverse event. With these major demands on pharmaceutical firms, its essential for...
by Anusha Thorati | Jun 9, 2020 | White Paper
Pharmacovigilance Pharmacovigilance (PV) is defined as the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problems. Background: WHO established its Program for International Drug...
by Jill Robinson | May 26, 2020 | White Paper
Introduction Pharmacovigilance (PV) is fundamental to the Pharmaceutical and Biotech industries. More now than ever, safety regulations are numerous and complex around the world. Regulatory authorities are requiring more safety documentation and review for...
Recent Comments